PRESS RELEASE published on 06/19/2025 at 22:59, 10 months 19 days ago Biophytis annonce la suspension provisoire de la cotation de son action Biophytis annonce la suspension provisoire de la cotation de son action par Euronext en raison du retard dans la publication de son rapport financier annuel 2024. Reprise de la cotation prévue après la certification des comptes Biophytis Euronext Rapport Financier Cotation Suspension
PRESS RELEASE published on 06/19/2025 at 22:59, 10 months 19 days ago Biophytis announces the temporary suspension of the trading of its shares Biophytis announces temporary suspension of trading of its shares by Euronext due to non-publication of annual financial report for 2024, expected to resume after report publication Biophytis Shares Euronext Trading Suspension
BRIEF published on 06/04/2025 at 07:05, 11 months 5 days ago Biophytis to Attend BIO International Convention in Boston Biophytis Biotechnology Partnerships BIO101 Convention
BRIEF published on 06/04/2025 at 07:05, 11 months 5 days ago Biophytis présente ses avancées à la BIO International Convention Biophytis Biotechnologie Partenariats Obésité Convention BIO
REGULATED PRESS RELEASE published on 06/04/2025 at 07:00, 11 months 5 days ago Biophytis annonce sa participation à la BIO International Convention du 16 au 19 juin Biophytis participera à la BIO International Convention du 16 au 19 juin 2025 à Boston, USA, pour présenter ses avancées et son candidat médicament BIO101 Biophytis Biotechnologie Boston BIO International Convention Maladies Liées À L'âge
REGULATED PRESS RELEASE published on 06/04/2025 at 07:00, 11 months 5 days ago Biophytis announces its participation in the BIO International Convention from June 16 to 19 Biophytis announces participation in BIO International Convention from June 16 to 19, 2025 in Boston, USA. Focus on drug candidate BIO101 and potential partnerships Biophytis Biotechnology Partnerships BIO International Convention Drug Candidate
BRIEF published on 05/30/2025 at 22:05, 11 months 9 days ago Biophytis Delays 2024 Annual Financial Report Publication Financial Statements Biophytis Shareholder Meeting Age-related Diseases Audit Delay
BRIEF published on 05/30/2025 at 22:05, 11 months 9 days ago Biophytis reporte la publication de ses comptes annuels 2024 Biophytis Assemblée Générale Comptes Annuels Audit Report
REGULATED PRESS RELEASE published on 05/30/2025 at 22:00, 11 months 9 days ago Information sur les comptes annuels Biophytis reporte la publication des comptes annuels 2024 en raison de complications techniques dans le processus d'audit. L'assemblée générale des actionnaires est également repoussée Biophytis Assemblée Générale Comptes Annuels Audit Report
REGULATED PRESS RELEASE published on 05/30/2025 at 22:00, 11 months 9 days ago Information on the Annual Financial Statements Biophytis postpones the publication of its 2024 annual financial statements due to technical complications in the audit process. The Company aims to complete the audit by the end of June 2025 Biophytis Audit Postponement 2024 Annual Financial Statements Technical Complications
Published on 05/09/2026 at 01:30, 10 hours 53 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 12 hours 23 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 15 hours 45 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 17 hours 10 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 17 hours 21 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 17 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 17 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 17 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 17 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 17 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
